Most studies of TGFB dysfunction in haematological malignancies have focussed on myeloid malignancies, given a higher frequency of specific oncoproteins and mutations in TGFB signalling components (reviewed by Bataller et al. [80]). The gene discussed is TGFB1; the disease is myeloid neoplasm.